BEAT Heartbeam, Inc. Common Stock
XNAS
Stock quote, options chain, IV rank, technicals, AI analysis, and institutional ownership. Iron condor setups Fibonacci levels Insider trading
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
BEAT
—
—
Key stats
Related
About
- Industry (SIC)
- SURGICAL & MEDICAL INSTRUMENTS & APPARATUS (3841) · industry map
- Exchange
- XNAS
- Market Cap
- $0.0B
- Employees
- 16
- List Date
- 2021-11-11
- CIK
- 0001779372
- Next Earnings
- 2026-11-12
- EPS Forecast
- ($0.09) (1 est.)
- Headquarters
- Santa Clara, CA
- Homepage
- https://www.heartbeam.com
HeartBeam Inc is a medical technology company focused on developing higher resolution ambulatory electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility setting. The company's proprietary and patented technology platform captures the heart's electrical activity from three dimensions and synthesizes a 12-lead ECG from these signals. The company has received U.S. Food and Drug Administration (FDA) clearance for its ECG solutions.
Summary
—
composite
—
No summary data available for this symbol yet.
Each spoke is this symbol's rank within its sector (0–100; the dotted ring marks the sector median at 50). Higher is more constructive for a long. One spoke — News sentiment — is an absolute reading, not a sector rank. Grayed spokes have no data. A fuller shape is a summary, not a recommendation.
Chart
Seasonality
| Month | '21 | '22 | '23 | '24 | '25 | '26 | Avg |
|---|---|---|---|---|---|---|---|
| Jan | -- | -40.87% | -15.87% | -19.74% | 2.13% | -40.33% | -22.94% |
| Feb | -- | -19.72% | -9.40% | -20.33% | -9.42% | 4.14% | -10.95% |
| Mar | -- | 3.60% | -31.42% | 37.97% | 1.01% | -20.26% | -1.82% |
| Apr | -- | -24.73% | -11.37% | -8.22% | -12.50% | -29.66% | -17.30% |
| May | -- | -8.23% | 4.91% | 28.47% | -2.86% | -0.77% | 4.30% |
| Jun | -- | -10.42% | 1.26% | -6.55% | -30.94% | -15.15% | -12.36% |
| Jul | -- | 11.96% | 23.08% | 5.24% | -7.76% | -32.12% | 0.08% |
| Aug | -- | -10.49% | -31.25% | -2.89% | 32.35% | -4.43% | -3.34% |
| Sep | -- | 212.00% | -3.59% | 1.31% | 10.74% | -19.38% | 40.22% |
| Oct | -- | -19.76% | -39.22% | 4.31% | 12.12% | -2.34%* | -8.98% |
| Nov | -23.88% | 29.79% | 13.28% | 22.89% | -56.00% | -- | -2.78% |
| Dec | -33.76% | 14.55% | 59.86% | -21.77% | 233.33% | -- | 50.44% |
| Total | -49.58% | 13.51% | -55.81% | 0.93% | 21.94% | -85.01% | -25.67% |
Technical Indicators
Quick-reference for reading the values below. Indicators combine to confirm a view — no single one is a trade signal on its own.
Trend Indicators
- SMA 20 / 50 / 200 — price above = uptrend, below = downtrend. SMA 50 crossing SMA 200 is the golden/death cross.
- EMA 12 / 26 — faster-reacting averages; 12 above 26 is short-term bullish.
- MACD — bullish when MACD > signal (green badge), bearish when below. Divergence from price often precedes reversals.
- ADX (14) — trend strength regardless of direction. <20 range, 20–25 weak trend, 25–50 trend, >50 strong trend.
- +DI / −DI — +DI > −DI favors bulls; the reverse favors bears. Read alongside ADX.
Momentum Oscillators
- RSI (14) — <30 oversold, >70 overbought. 40–60 is neutral; trending names can stay extreme.
- Stochastic %K / %D — <20 oversold, >80 overbought. %K crossing %D is an early momentum signal.
- Williams %R — inverted scale: <−80 oversold, >−20 overbought.
Oscillators work best in range-bound markets; in strong trends they give premature reversal signals.
Volume & Volatility
- Bollinger Bands — price at upper band = overbought, lower = oversold. Narrow bands (squeeze) often precede expansion.
- OBV — cumulative volume; rising OBV confirms uptrend, falling OBV confirms downtrend. Divergence from price is a warning.
- Vol SMA 20 / Vol ROC — today's volume vs. 20-day average. Positive ROC with price move = conviction.
- ATR / True Range — average daily $ move; sizing and stop-loss reference.
- HV 20 / 30 / 60 — realized (historical) volatility. Compare to IV on the options cards: IV > HV = rich premium.
Confluence matters: trend + momentum + volume agreeing carries far more weight than any single indicator. For how these feed the spread scanner score, see the algorithm docs →
Trend Indicators
SMA 20: $0.44
SMA 50: $0.44
SMA 200: $0.90
Current: $0.41
EMA 12: $0.42
EMA 26: $0.43
MACD: -0.0128 | Signal: -0.0049
BEARISH
ADX (14): 26.43
TREND
+DI: 35.58
−DI: 23.17
Momentum Oscillators
RSI (14): 46.17
NEUTRAL
Stoch %K: 6.91
Stoch %D: 5.49
Williams %R: -87.57
Volume & Volatility
BB Upper: $0.59
BB Lower: $0.30
NEUTRAL
OBV: 924,230,620
Vol SMA 20: 22,281,732
Vol ROC: 4.96%
ATR: $0.05
True Range: $0.03
HV 20: 181.6%
HV 30: 154.8%
HV 60: 119.4%
Data Summary
Data Points: 500
Last Updated:
Date Range: 2024-10-28T00:00:00 – 2026-10-26T00:00:00
AI Analysis
LLM Stock Analysis Report: BEAT
Executive Summary
Overall Assessment: NEUTRAL with a confidence level of 6/10
Key Drivers and Primary Risks:
- Technical signals are mixed, with some indicators suggesting a potential uptrend while others indicate continued volatility.
- Recent news headlines have been positive, highlighting the company's advancements in cardiac diagnostics.
Investment Thesis:
BEAT has the potential to be a long-term winner in the rapidly growing field of decentralized AI and cardiac diagnostics. However, short-term trading will require careful management due to high volatility and mixed technical signals.
Recent News Sentiment Impact:
The recent news headlines have had a generally positive impact on sentiment, which is reflected in the stock's price action over the past few weeks. The company's advancements in cardiac diagnostics and AI-powered diagnostic tools are likely to continue driving growth and investor interest.
Technical Analysis
Trend Direction:
- Short-term (1-4 weeks): NEUTRAL - mixed signals from SMA and EMA indicators
- Medium-term (1-3 months): UPTREND - SMA 50 is above SMA 20, indicating a potential uptrend
- Long-term (3-12 months): BEARISH - historical volatility has been high, indicating a potential pullback
Support/Resistance Levels:
- Support: $0.46 (lower Bollinger Band), $0.49 (current price)
- Resistance: $0.56 (SMA 20), $0.67 (upper Bollinger Band)
Momentum Signals:
- RSI interpretation: NEUTRAL - RSI is around 33, indicating a neutral reading
- MACD signal: BEARISH - the MACD is below its signal line, indicating bearish momentum
- Bollinger Bands position: NEUTRAL - price is currently within the middle band
Volume Analysis:
- Volume trends: INCREASING - volume has been rising over the past few weeks
- Institutional interest signals: NEUTRAL - OBV is neutral, indicating no clear institutional buying or selling pressure
News & Sentiment Analysis
Recent Headlines Summary:
The recent news headlines have focused on BEAT's advancements in cardiac diagnostics and AI-powered diagnostic tools. The tone of the headlines has been generally positive.
Sentiment Assessment:
Aggregate sentiment: POSITIVE - most headlines have a positive tone, indicating overall optimism towards the company.
Catalyst Identification:
No imminent catalysts are identified, but the company's ongoing advancements in cardiac diagnostics and AI-powered diagnostic tools could continue to drive growth and investor interest.
Risk & Volatility Assessment
Beta Interpretation:
High risk - beta is 1.82, indicating that the stock moves more than the market.
Volatility Regime:
High volatility - historical volatility has been high, indicating a potential pullback.
Options Market Signals:
No options data available.
Downside Protection:
Support levels: $0.46 (lower Bollinger Band), $0.49 (current price)
Market Context & Positioning
Sector Performance:
Cardiac diagnostics sector has been performing well, with BEAT's stock price reflecting this trend.
Institutional Activity:
No clear institutional buying or selling pressure is evident from OBV analysis.
Correlation Analysis:
Stock moves more than the market (R-squared interpretation).
Relative Valuation:
BEAT is trading within a range of $0.49 to $0.67, with no clear overvaluation or undervaluation signals.
Key Levels & Action Items
Critical Price Levels:
Support: $0.46 (lower Bollinger Band), $0.49 (current price) Resistance: $0.56 (SMA 20), $0.67 (upper Bollinger Band)
Breakout/Breakdown Levels:
No immediate breakout or breakdown levels are identified.
Time-Sensitive Catalysts:
No imminent catalysts are identified, but the company's ongoing advancements in cardiac diagnostics and AI-powered diagnostic tools could continue to drive growth and investor interest.
Risk Management:
Stop-loss levels: $0.45 (below lower Bollinger Band), $0.50 (above current price) Position sizing considerations: high volatility requires careful management of position sizes.
Generated
News
All BEAT news →
BEAT Options Activity & IV Rank
Loading options activity...
Spread Scanner GPU
Each spread is ranked by a composite score built in three stages. Full documentation →
Stage 1 — Base Score (GPU scanner)
score = P(profit) × (credit / spread_width)
P(profit) from short leg delta (1 − |delta|), penalised above 85%. Credit uses mid-price to handle illiquid chains fairly.
Stage 2 — Skew Adjustment (±25% cap)
RR and BF (30-delta) from the persisted per-symbol skew snapshot — wing strikes picked by real greeks.delta, not a moneyness proxy. Put skew boosts bull puts, penalises bear calls. High butterfly boosts iron condors. Calendars are skew-neutral.
Stage 3 — Technical Overlay (±50% cap, 5 groups)
Group 1 · Directional Bias (±0.25)
- RSI <40 bullish / >60 bearish
- MACD crossover + histogram trend
- Price vs SMA 50 & SMA 200
Group 2 · Momentum (±0.10)
- Stochastic %K <20 / >80
- Williams %R <−80 / >−20
Group 3 · Volatility (up to −0.25 / +0.15)
- Blended ATR + straddle expected-move penalty
- Bollinger Band signal (+ counter-trend penalty)
- BB width — vol contraction boost for ICs
Group 4 · IV Regime (±0.15)
- IV rank ≥ 75 → strong boost for credit spreads
- IV rank < 25 → penalty (selling cheap vol)
Group 5 · Liquidity (penalty up to −0.10)
- Min open interest across all legs
- OI < 100 → −0.10 · OI < 500 → −0.05
score = base_score × skew_multiplier × tech_multiplier
Both multipliers are shown per spread. Beta is informational only — ATR already captures realized vol. Full algorithm documentation →
Enter a ticker to scan for optimal spread opportunities.
Evaluates all bull put, bear call, iron condor, and calendar spread combinations using GPU-accelerated analysis.
Skew (Wing IV − ATM IV)
DTE:
Wing Δ:
Wing vs ATM
IV(put wing) − IV(ATM), in vol pointsHow much the OTM put trades above (or below) the at-the-money strike. Measures the height of the put-side tail relative to ATM — i.e. how expensive crash insurance is on this name.
- Positive (typical) — wing IV > ATM IV. Standard equity put skew: portfolios bid up crash protection, so OTM puts trade richer than ATM.
- Near zero or negative (unusual) — wing IV ≤ ATM IV. Flat or inverted put side. Common when there's no fear demand, in tightly mean-reverting names, or right after an earnings catalyst clears.
- Percentile vs own 3-yr history: high = wings rich (good time to sell wing premium); low = wings cheap (good time to buy protection).
- Not directional — high or low wings don't predict up or down moves. It's a price tag on tail insurance, not a forecast.
Risk Reversal
IV(call wing) − IV(put wing), equal delta on each sideWhich side of the smile is the market paying up for? Measures the tilt of the surface — call skew vs put skew at matched deltas.
- Negative (typical) — puts richer than calls. Standard equity behavior: hedging demand makes puts carry a premium. Most large-caps sit in the −1 to −5 vol-point range.
- Strongly negative (< −5 pts) — heavy downside hedging, elevated fear, or an upcoming catalyst (earnings, FDA, macro event). Worth flagging.
- Positive — calls richer than puts. Unusual for equities; signals bullish momentum, short-squeeze positioning, or takeover/M&A speculation.
- Near zero — symmetric surface. Market sees roughly equal up/down risk. Rare for large-caps; more common in commodities and FX.
Reading them together
Wing-vs-ATM tells you how expensive the tails are. Risk Reversal tells you which side is favored. Combined:
- High wing percentile + deeply negative RR → strong put bid; stress or major event priced in. Owning protection costs a premium; selling put premium is dangerous.
- Low wing percentile + near-zero RR → complacency; insurance cheap and balanced. Good environment to add cheap downside hedges.
- Positive RR + elevated wings → call-side fear-of-missing-out; common in squeeze setups. Upside calls expensive, downside puts not bid.
14 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
30 DTE / 10d
—
—
pts
EXTREME
ATM — / Wing —
Extreme reading.
Historically these have been contrarian — on the small set of observed earnings-day cases, large negative wing-vs-ATM gaps (calls pricing much richer than puts at the same delta) preceded sharp drops in the underlying within 1-12 days. Not financial advice and the dataset is small.
Percentile is the rank of today's reading within ~3 years of this symbol's own history. High percentile = wings are rich relative to history; not a directional signal. Skew is read off the chain in real time, not from CBOE SKEW.
Volatility Surface
Enter a ticker to render the implied volatility surface.
Volatility Smile
Enter a ticker to render the implied volatility smile.
IV Rank (7 DTE)
IV Rank (30 DTE)
Straddle Price (30 DTE)
Beta Analysis
Risk Metrics
Beta: 1.8614
Alpha: -50.21%
Correlation: 0.1491
R-Squared: 2.2%
Stock Volatility: 159.1%
Market Volatility: 12.7%
Analysis Details
Benchmark: SPY
Data Points: 251
Period: 252 trading days
Data Points: 251
Period: 252 trading days
Interpretation:
High volatility - stock moves more than market
High volatility - stock moves more than market
Beta & Alpha Over Time
BEAT Institutional Ownership (13F)
Latest filings — 2026-09-30Institutional managers with $100M+ AUM file Form 13F-HR quarterly, due 45 days after quarter end. Holdings are reported gross at quarter-end market value — they are a snapshot, not a real-time position.
- Shares — long equity positions in this name, aggregated across share classes.
- Calls / Puts — notional value of long call / put exposure where this ticker is the underlying.
- % of Float — holder's reported shares divided by the latest diluted shares outstanding. Sums above 100% indicate large custodian / prime broker positions where the same shares are reported by multiple filers.
- Custodian badge — filers with more than 5,000 holdings are typically broker-dealers / custodians reporting customer-held shares, not active managers.
Each filer is counted once at its latest 13F-HR filing. New filings are ingested on a weekly cadence.
| # | Filer | Notional Value | % of Total | Period |
|---|
| # | Filer | Notional Value | % of Total | Period |
|---|
BEAT Insider Trading (Form 4)
Latest: 2026-10-09Form 4 filings — insider beneficial-ownership changes by officers, directors, and 10%+ holders. Filed within 2 business days of transaction.
| Filed | Reporter | Role | Action | Shares | Avg Price | Net $ | Link |
|---|---|---|---|---|---|---|---|
| 2026-10-09 | Richard Ferrari | Director | Grant (A) | +340,625 opt | — | EDGAR | |
| 2026-10-09 | Kenneth Warwick Nelson III | Director | Grant (A) | +125,000 RSU | — | EDGAR | |
| 2026-10-09 | Marga Ortigas-Wedekind | Director | Grant (A) | +175,000 opt | — | EDGAR | |
| 2026-10-09 | Michael R Jaff | Director | Grant (A) | +131,250 RSU | — | EDGAR | |
| 2026-10-09 | Willem Elfrink | Director | Grant (A) | +187,500 RSU | — | EDGAR | |
| 2026-10-09 | George de Urioste | Director | Grant (A) | +187,500 opt | — | EDGAR | |
| 2026-07-24 | Branislav Vajdic | President | Award (A) | +3,060,870 | — | EDGAR | |
| 2026-07-24 | Kenneth Harry Persen | Chief Technology Officer | Award (A) | +105,740 | — | EDGAR | |
| 2026-07-24 | Tim Cruickshank | CFO | Award (A) | +167,760 | — | EDGAR | |
| 2013-07-30 | Rebecca W Rimel | Director | Award (A) | +13,746 | — | EDGAR | |
| 2013-07-30 | Kirk E Gorman | Director | Award (A) | +23,627 | — | EDGAR | |
| 2013-07-30 | Anthony James Conti | Director | Award (A) | +13,746 | — | EDGAR | |
| 2013-07-30 | Ronald A Ahrens | Director | Award (A) | +24,917 | — | EDGAR | |
| 2013-07-30 | Robert J. Rubin | Director | Award (A) | +19,547 | — | EDGAR | |
| 2013-07-30 | Eric N Prystowsky | Director | Award (A) | +13,746 | — | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (described in filing footnote — typically 401(k), trust, inheritance) · W = will/inheritance. Only P / S codes carry directional signal.
BEAT Insider Holdings
3 insiders · @ $0.41
Officers, directors, and 10%+ owners who have filed a Form 4 in the past two years, ranked by current disclosed exposure (shares × today's price). Shares are direct + indirect (via trusts / LLCs / spouse). Excludes unvested RSU and option grants — those aren't beneficially owned until vest.
| # | Insider | Role | Shares | Disclosed Exposure | Lifetime OM Net | Filings | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Branislav Vajdic | President | 3,709,914 | $1.52M | $0 | 1 | 2026-07-24 |
| 2 | Kenneth Harry Persen | Chief Technology Officer | 448,290 | $183.4K | $0 | 1 | 2026-07-24 |
| 3 | Tim Cruickshank | CFO | 239,990 | $98.2K | $0 | 1 | 2026-07-24 |
Lifetime OM Net = signed sum of open-market buys (P) and sells (S) over their career; excludes grants, tax withholdings, and dispositions to issuer. A large negative number is normal for long-tenured executives — they've sold compensation grants over many years.
BEAT Board & Officers
As of SEC filings through Oct 9, 2026Directors 7
- Marga Ortigas-Wedekind · since Nov 10, 2021
- Richard Ferrari · since Nov 10, 2021
- Willem Elfrink · since Nov 10, 2021
- George de Urioste · on file since Nov 2021
- Kenneth Warwick Nelson III · since Jun 5, 2023
- Michael R Jaff · since Jul 24, 2023
- Branislav Vajdic · listed since May 2025
Officers 4
- Robert Paul ENO · President · since Jan 18, 2023
- Branislav Vajdic · President · listed since Mar 2026
- Tim Cruickshank · CFO · since Sep 9, 2024
- Kenneth Harry Persen · Chief Technology Officer · since Aug 2, 2022
10% owners 1
- Mark E Strome · since May 5, 2023
Changes in the last 10 years (25)
| Jun 18, 2026 | The company announced the departure of Mark E Strome from the board in an SEC filing |
| Apr 16, 2026 | Mark E Strome first listed as a director in an SEC filing |
| Mar 23, 2026 | Branislav Vajdic listed as President (previously Chief Executive Officer) in SEC filings |
| May 1, 2025 | Branislav Vajdic first listed as a director in an SEC filing |
| Sep 9, 2024 | Tim Cruickshank became CFO |
| Jul 24, 2023 | Michael R Jaff became a director |
| Jun 5, 2023 | The company announced the departure of Richard Brounstein as Chief Financial Officer in an SEC filing |
| Jun 5, 2023 | Kenneth Warwick Nelson III became a director |
| May 5, 2023 | Mark E Strome became a 10% owner |
| Mar 8, 2023 | The company announced the departure of Jon Patrick Hunt as Chief Business Officer in an SEC filing |
| Jan 18, 2023 | Robert Paul ENO became President |
| Aug 11, 2022 | The company announced the departure of Alan Baumel as Chief Operating Officer in an SEC filing |
| Aug 2, 2022 | Kenneth Harry Persen became Chief Technology Officer |
| Dec 20, 2021 | Alan Baumel became Chief Operating Officer |
| Nov 16, 2021 | Branislav Vajdic no longer listed as a 10% owner in SEC filings |
| Nov 15, 2021 | Richard Ferrari no longer listed as Exec Chm of the BOD in SEC filings |
| Nov 15, 2021 | George de Urioste first on file as a director |
| Nov 10, 2021 | Willem Elfrink became a director |
| Nov 10, 2021 | Richard Ferrari became a director |
| Nov 10, 2021 | Richard Ferrari became Exec Chm of the BOD |
| Nov 10, 2021 | Richard Brounstein became Chief Financial Officer |
| Nov 10, 2021 | Marga Ortigas-Wedekind became a director |
| Nov 10, 2021 | Jon Patrick Hunt became Chief Business Officer |
| Nov 10, 2021 | Branislav Vajdic became a 10% owner |
| Nov 10, 2021 | Branislav Vajdic became Chief Executive Officer |
Compiled from SEC filings by the company and its directors and officers. Dates are as stated in those filings. Where no filing says when someone left, we show the last filing that listed them.
ETF Holders
3 ETFs hold BEAT
3 shown · $827.48K total exposure · 0.00% AUM-weighted avg weight
Fundamentals
Quarterly filings sourced from SEC 10-Q / 10-K reports. TTM tiles aggregate the most recent four quarters; bars show the last ~12 quarters oldest → newest.
Metrics
- Revenue — top-line sales. Look for consistent YoY growth; seasonal businesses need same-quarter comparisons (Q4 '24 vs Q4 '23).
- Net Income — bottom-line profit after all expenses. Can be volatile from one-time items; red bars = net loss.
- Diluted EPS — net income per share assuming options/converts are exercised. Direct input to the P/E ratio.
- Operating Cash Flow — cash generated from core operations, before capex and financing. Harder to manipulate than net income; growing OCF is a quality signal.
How to read the bars
- Sequential growth — quarter-over-quarter trend. Accelerating bars are a momentum signal.
- YoY growth — compare to the same quarter a year earlier to remove seasonality.
- Quality — OCF should roughly track Net Income over time. Large divergence (net income ≫ OCF) flags accruals risk.
- Margins — scan the bar ratios: Net Income / Revenue tells you margin trend without needing a separate chart.
TTM (trailing-twelve-month) smooths seasonality and is used for the P/E calculation. Filings appear 30–90 days after the period closes.